Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04614103 |
| Consolidated Lead Sponsor | Iovance Biotherapeutics |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 170 participants (ESTIMATED) |
| Registered Start Date | 2021-05-07 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Moffitt Cancer Center | Tampa, FL | Open Hospital Dossier -> |
| Rush University Medical Center | Chicago, IL | Open Hospital Dossier -> |
| University of Louisville | Louisville, KY | Open Hospital Dossier -> |
| University of Maryland | Baltimore, MD | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.